Search research articles
Contact Us
Filters
Showing results (131-140 of 169) with videos related to
Page
of 17
Sort By:
Psychiatrische Praxis
|
October 9, 2024
[Developing An Initial Best Practice Model For Inpatient Equivalent Psychiatric Home Treatment From The Perspective Of Service Users: Consensus Process With Participatory Features]
Julian Schwarz, Kim Scheunemann, Hannah Mundry, et al.
Schizophrenia Bulletin Open
|
August 15, 2024
<i>N</i>-Acetylcysteine and a Specialized Preventive Intervention for Individuals at High Risk for Psychosis: A Randomized Double-Blind Multicenter Trial
Sven Wasserthal, Ana Muthesius, René Hurlemann, et al.
International Journal of Bipolar Disorders
|
July 2, 2020
Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)
Andrea Pfennig, Karolina Leopold, Julia Martini, et al.
International Journal of Bipolar Disorders
|
February 18, 2025
Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife)
Johanna Glaus, Anne Karow, Martin Lambert, et al.
International Journal of Bipolar Disorders
|
December 10, 2025
Advancing the prediction of factors associated with bipolar disorder risk: utilizing early recognition tools and polygenic risk scores
Silvia Biere, Silke Matura, Kristiyana Petrova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 14, 2019
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)
Paolo Fusar-Poli, Michael Bauer, Stefan Borgwardt, et al.
JAMA Psychiatry
|
November 21, 2012
The psychosis high-risk state: a comprehensive state-of-the-art review
Paolo Fusar-Poli, Stefan Borgwardt, Andreas Bechdolf, et al.
Schizophrenia Bulletin
|
April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.
Bipolar Disorders
|
March 1, 2020
Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study
Karolina Leopold, Michael Bauer, Andreas Bechdolf, et al.
Trials
|
August 3, 2025
A mechanism-based group psychotherapy approach to aggressive behavior (MAAP) in borderline personality disorder: a multicenter randomized controlled clinical trial
Christine Sigrist, Andreas Bechdolf, Katja Bertsch, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 169) with videos related to
Sort By:
Page
of 17
Psychiatrische Praxis
|
October 9, 2024
[Developing An Initial Best Practice Model For Inpatient Equivalent Psychiatric Home Treatment From The Perspective Of Service Users: Consensus Process With Participatory Features]
Julian Schwarz, Kim Scheunemann, Hannah Mundry, et al.
Schizophrenia Bulletin Open
|
August 15, 2024
<i>N</i>-Acetylcysteine and a Specialized Preventive Intervention for Individuals at High Risk for Psychosis: A Randomized Double-Blind Multicenter Trial
Sven Wasserthal, Ana Muthesius, René Hurlemann, et al.
International Journal of Bipolar Disorders
|
July 2, 2020
Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)
Andrea Pfennig, Karolina Leopold, Julia Martini, et al.
International Journal of Bipolar Disorders
|
February 18, 2025
Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife)
Johanna Glaus, Anne Karow, Martin Lambert, et al.
International Journal of Bipolar Disorders
|
December 10, 2025
Advancing the prediction of factors associated with bipolar disorder risk: utilizing early recognition tools and polygenic risk scores
Silvia Biere, Silke Matura, Kristiyana Petrova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 14, 2019
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)
Paolo Fusar-Poli, Michael Bauer, Stefan Borgwardt, et al.
JAMA Psychiatry
|
November 21, 2012
The psychosis high-risk state: a comprehensive state-of-the-art review
Paolo Fusar-Poli, Stefan Borgwardt, Andreas Bechdolf, et al.
Schizophrenia Bulletin
|
April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.
Bipolar Disorders
|
March 1, 2020
Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study
Karolina Leopold, Michael Bauer, Andreas Bechdolf, et al.
Trials
|
August 3, 2025
A mechanism-based group psychotherapy approach to aggressive behavior (MAAP) in borderline personality disorder: a multicenter randomized controlled clinical trial
Christine Sigrist, Andreas Bechdolf, Katja Bertsch, et al.
Page
of 17